您的位置: 首页 > 农业专利 > 详情页

COMPOSITION AMÉLIORANT L'IMMUNITÉ ANTITUMORALE CONTENANT L'ADÉNOVIRUS EXPRIMANT SIMULTANÉMENT IL-12 ET SHVEGF
专利权人:
Industry - University Cooperation Foundation Hanyang University
发明人:
申请号:
EP16842279.8
公开号:
EP3329934A1
申请日:
2016.08.31
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention relates to an oncolytic adenovirus co-expressing interleukin (IL-12) and shVEGF and a composition for enhancing an anticancer effect. The inventors confirmed that, when VEGF suppression and IL-12 expression are co-expressed in immunocompetent murine melanoma or kidney cancer models, an immune function is restored and an anticancer effect is improved. Particularly, it has been revealed that such an improved anticancer effect is associated with an increase in anticancer immunity, an increase in Th1 cytokines and prevention of tumor-induced thymic atrophy, and therefore the applicability of a gene delivery system co-expressing IL-12 and shVEGF to cancer gene therapy was identified for the first time.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充